SLC29A3 and anemia: Moreover, HSC transplantation in Slc29a3-null mice increased survivability with notable improvement in health, whereas treatment with synthetic adenosine analogs (e.g., AICAR) resulted in only a partial recovery of ENT3 dysfunctions, including anemia, in Slc29a3 KO mice [190].